Exchange: NYSEMkt·Updated 04:04 PM EDT
Latest Earnings Results: Q3 '26

Reported: Aug 13

Estimated EPS

-$2.90

Reported EPS

---

Surprise

---

Estimated Rev

$17.97M

Reported Rev

---

Surprise

---

Pelthos Therapeutics Inc. reported net product revenues of $15.4 million for the three months ended June 30, 2026, and $26.1 million for the six months ended June 30, 2026.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
--
-$6.87
--
N/A
Q3 '26
-$2.90
--
--
N/A
Q2 '26
-$2.82
-$6.62
-134.87%
MISSED
Q1 '26
-$3.45
-$3.09
10.43%
BEAT
Q4 '25
-$3.70
-$6.87
-85.84%
MISSED

Advertisement|Remove ads.